| Mesoporous silica nanoparticles as pH-responsive carrier for the immune-activating drug resiquimod enhance the local immune response in mice J Wagner, D Gößl, N Ustyanovska, M Xiong, D Hauser, O Zhuzhgova, ... ACS nano 15 (3), 4450-4466, 2021 | 104 | 2021 |
| Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer B Taskoparan, EG Seza, S Demirkol, S Tuncer, M Stefek, AO Gure, ... Cellular Oncology 40, 563-578, 2017 | 48 | 2017 |
| CHNQ, a novel 2-Chloro-1, 4-naphthoquinone derivative of quercetin, induces oxidative stress and autophagy both in vitro and in vivo S Enayat, MŞ Ceyhan, B Taşkoparan, M Stefek, S Banerjee Archives of Biochemistry and Biophysics 596, 84-98, 2016 | 27 | 2016 |
| General toxicity assessment of the novel aldose reductase inhibitor cemtirestat MŠ Prnová, L Račková, L Kováčiková, J Balleková, J Viskupičová, ... Interdisciplinary toxicology 12 (3), 120-128, 2019 | 6 | 2019 |
| HDR-based CRISPR/Cas9-mediated Knockout of PD-L1 in C57BL/6 Mice LV Heeb, B Taskoparan, A Katsoulas, M Beffinger, PA Clavien, S Kobold, ... Bio-protocol 13 (14), 2023 | | 2023 |
| Investigating the cellular effects of the aldo-keto reductases AKR1B1 and AKR1B10 in HCT-116 colon cancer cells B Taskoparan, EG Seza, MS Ceyhan, S Banerjee | | 2016 |
| Aldo Keto Redüktaz İnhibitorü Olan Kuersetin ve Onun Türevi CHNQ Maddelerinin Karakterizasyonu ve Kolon Kanser Üzerine Fonksiyonel Etkilerinin Araştırılması B TAŞKOPARAN, S BANERJEE, EG SEZA | | 2016 |
| Effects of the quercetin derivative CHNQ, a potent aldo-keto reductase inhibitor, on akr1b1 silenced HCT-116 colorectal cancer cells B Taşkoparan Middle East Technical University, 2016 | | 2016 |
| Aldo Keto Redüktaz İnhibitorü Olan Kuersetin ve Onun Türevi CHNQ Maddelerinin Karakterizasyonu ve Kolon Kanser Üzerine Fonksiyonel Etkilerinin Araştırılması GE Seza, S Banerjee, B Taşkoparan | | 2016 |
| Effects of AKR1B1 silencing in HCT-116 colon cancer cells. B Taşkoparan, M CEYHAN, S TUNÇER, M Stefek, S BANERJEE | | |
